Pharmaceutical

STAT+: FDA issues warning to wholesaler sued by Gilead ...

The FDA has issued a warning to a drug wholesaler that was also sued by Gilead a...

STAT unveils a new look, and color. Our executive edito...

STAT has unveiled a new homepage redesign, and color. Our executive editor @rick...

STAT+: After late start, Eli Lilly has the momentum in ...

Lilly shows off data that suggests it could soon have a potent new injectable an...

STAT+: Global controversy heats up the race to build hu...

Scientists worry the recent controversy over human embryo models could lead to r...

STAT+: Lilly reaches $2.4 million settlement with EEOC ...

Eli Lilly agreed to pay $2.4 million as part of a settlement with the U.S. Equal...

STAT+: Pharmalittle: Lilly drug shows biggest weight lo...

Eli Lilly disclosed results showing an experimental drug that targets three horm...

For volunteers at an eating disorder hotline, being rep...

“This is a job I undertook not only as somebody who is recovered from an eating ...

STAT+: Grail faces uphill battle to get Medicare to cov...

Medicare covers FDA-approved medicines and devices that help diagnose or treat d...

Opinion: A seemingly small semantic issue is a major ro...

Clarifying this distinction will help accelerate the development of cures for ra...

GSK obtains approval in Japan for shingles vaccine

The Japanese MHLW has granted approval for a renewed indication of GSK's shingle...

Tonix to acquire Upsher-Smith’s migraine products

Tonix Pharmaceuticals and Tonix Medicines have signed an agreement for the acqui...

EC approves BMS’ Camzyos for hypertrophic cardiomyopathy

The European Commission has approved Bristol Myers Squibb’s Camzyos to treat sym...

Vertex and Lonza to establish T1D cell therapy manufact...

Vertex and Lonza have entered a partnership to establish a facility in Portsmout...

Lisata shares pipeline update of anticancer lead candid...

Lisata aims to finish enrolment of its Phase II trial in solid tumours by the en...

Pfizer takes on haemophilia B gene therapy market with ...

The FDA has accepted a biologics license application (BLA) for Pfizer's fidanaco...

Rystiggo receives FDA approval, strengthening UCB’s mya...

UCB's Rystiggo has been granted FDA approval to treat myasthenia gravis in anti-...